S T A T E   O F   N E W   Y O R K
       ________________________________________________________________________
                                          468
                              2015-2016 Regular Sessions
                                 I N  A S S E M B L Y
                                      (PREFILED)
                                    January 7, 2015
                                      ___________
       Introduced  by M. of A. CYMBROWITZ, MAGEE, BRINDISI, GUNTHER, RUSSELL --
         Multi-Sponsored by -- M. of A. LUPARDO -- read once  and  referred  to
         the Committee on Consumer Affairs and Protection
       AN  ACT  to  amend  the general business law, in relation to the sale of
         over-the-counter methamphetamine precursor drugs
         THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
       BLY, DO ENACT AS FOLLOWS:
    1    Section 1. The general business law is amended by adding a new section
    2  391-oo to read as follows:
    3    S 391-OO. SALE OF METHAMPHETAMINE PRECURSOR DRUGS. 1. FOR THE PURPOSES
    4  OF THIS SECTION:
    5    (A) "METHAMPHETAMINE PRECURSOR DRUG" SHALL MEAN ANY COMPOUND, MIXTURE,
    6  OR  PREPARATION  CONTAINING  EPHEDRINE  OR  PSEUDOEPHEDRINE  AS ITS SOLE
    7  ACTIVE INGREDIENT OR AS ONE OF ITS ACTIVE INGREDIENTS; AND
    8    (B) "REAL-TIME STOP SALE SYSTEM" MEANS A SYSTEM INTENDED TO BE USED BY
    9  LAW ENFORCEMENT AGENCIES AND PHARMACIES OR OTHER BUSINESS ESTABLISHMENTS
   10  THAT:
   11    (A) IS INSTALLED, OPERATED, AND MAINTAINED FREE  OF  ANY  ONE-TIME  OR
   12  RECURRING CHARGE TO THE BUSINESS ESTABLISHMENT OR TO THE STATE;
   13    (B)  IS ABLE TO COMMUNICATE IN REAL TIME WITH SIMILAR SYSTEMS OPERATED
   14  IN OTHER STATES AND SIMILAR SYSTEMS CONTAINING INFORMATION SUBMITTED  BY
   15  MORE THAN ONE STATE;
   16    (C) COMPLIES WITH THE SECURITY POLICY OF THE CRIMINAL JUSTICE INFORMA-
   17  TION SERVICES DIVISION OF THE FEDERAL BUREAU OF INVESTIGATION;
   18    (D)  COMPLIES  WITH  INFORMATION  EXCHANGE  STANDARDS  ADOPTED  BY THE
   19  NATIONAL INFORMATION EXCHANGE MODEL;
   20    (E) USES A MECHANISM TO PREVENT THE COMPLETION OF A SALE OF A  PRODUCT
   21  CONTAINING EPHEDRINE, PSEUDOEPHEDRINE, OR NON-PSEUDOEPHEDRINE THAT WOULD
   22  VIOLATE  STATE  OR  FEDERAL  LAW  REGARDING  THE  PURCHASE  OF A PRODUCT
   23  CONTAINING THOSE SUBSTANCES; AND
        EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                             [ ] is old law to be omitted.
                                                                  LBD01970-01-5
       A. 468                              2
    1    (F) IS EQUIPPED WITH AN OVERRIDE OF THE MECHANISM THAT:
    2    (I) MAY BE ACTIVATED BY AN EMPLOYEE OF A BUSINESS ESTABLISHMENT; AND
    3    (II) CREATES A RECORD OF EACH ACTIVATION OF THE OVERRIDE.
    4    2.  NO  PERSON,  FIRM,  CORPORATION, PARTNERSHIP, ASSOCIATION, LIMITED
    5  LIABILITY COMPANY, OR OTHER ENTITY SHALL SELL TO THE SAME PERSON, AND  A
    6  PERSON  SHALL  NOT PURCHASE, PRODUCTS CONTAINING MORE THAN THREE AND SIX
    7  TENTHS GRAMS PER DAY OR MORE THAN NINE GRAMS PER THIRTY  DAY  PERIOD  OF
    8  EPHEDRINE  OR  PSEUDOEPHEDRINE  BASE, OR THEIR ISOMERS. THE LIMITS SHALL
    9  APPLY TO THE TOTAL AMOUNT OF EPHEDRINE AND PSEUDOEPHEDRINE CONTAINED  IN
   10  THE PRODUCTS, AND NOT THE OVERALL WEIGHT OF THE PRODUCTS.
   11    3.  ANY  PERSON,  FIRM, CORPORATION, PARTNERSHIP, ASSOCIATION, LIMITED
   12  LIABILITY COMPANY, OR OTHER ENTITY THAT OFFERS FOR SALE  METHAMPHETAMINE
   13  PRECURSOR  DRUGS IN AN OVER-THE-COUNTER SALE SHALL ENSURE THAT ALL PACK-
   14  AGES OF THE DRUGS ARE DISPLAYED BEHIND A CHECKOUT COUNTER OR IN A LOCKED
   15  CASE WHERE THE PUBLIC IS NOT PERMITTED. SUCH PERSON, FIRM,  CORPORATION,
   16  PARTNERSHIP,  ASSOCIATION,  LIMITED  LIABILITY  COMPANY, OR OTHER ENTITY
   17  SHALL:
   18    (A) REQUIRE ANY  PERSON  PURCHASING  A  NONPRESCRIPTION  PRODUCT  THAT
   19  CONTAINS PSEUDOEPHEDRINE OR EPHEDRINE TO PRESENT VALID GOVERNMENT ISSUED
   20  PHOTO IDENTIFICATION AT THE POINT OF SALE.
   21    (B) RECORD THE NAME AND ADDRESS OF THE PURCHASER; NAME AND QUANTITY OF
   22  PRODUCT PURCHASED; DATE AND TIME PURCHASED; AND PURCHASER IDENTIFICATION
   23  TYPE  AND  NUMBER,  SUCH AS DRIVER LICENSE STATE AND NUMBER, AND REQUIRE
   24  THE PURCHASER'S SIGNATURE IN A ELECTRONIC OR PAPER LOGBOOK.
   25    4. A PERSON,  FIRM,  CORPORATION,  PARTNERSHIP,  ASSOCIATION,  LIMITED
   26  LIABILITY COMPANY, OR OTHER ENTITY SHALL, BEFORE COMPLETING A SALE UNDER
   27  THIS  SECTION,  ELECTRONICALLY  SUBMIT  THE  REQUIRED INFORMATION TO THE
   28  REAL-TIME STOP SALE SYSTEM ADMINISTERED BY THE DIVISION OF STATE POLICE;
   29  PROVIDED THAT THE SYSTEM IS AVAILABLE WITHOUT A CHARGE TO RETAILERS  FOR
   30  ACCESS.  ABSENT  NEGLIGENCE,  WANTONNESS,  RECKLESSNESS,  OR  DELIBERATE
   31  MISCONDUCT, ANY RETAILER UTILIZING THE ELECTRONIC SALES TRACKING  SYSTEM
   32  IN  ACCORDANCE  WITH  THIS  SUBDIVISION SHALL NOT BE CIVILLY LIABLE AS A
   33  RESULT OF ANY ACT OR OMISSION IN CARRYING OUT  THE  DUTIES  REQUIRED  BY
   34  THIS  SECTION  AND  SHALL  BE  IMMUNE  FROM LIABILITY TO ANY THIRD PARTY
   35  UNLESS THE RETAILER HAS  VIOLATED  ANY  PROVISION  OF  THIS  SECTION  IN
   36  RELATION TO A CLAIM BROUGHT FOR SUCH VIOLATION.
   37    (A)  IF A PERSON, FIRM, CORPORATION, PARTNERSHIP, ASSOCIATION, LIMITED
   38  LIABILITY COMPANY, OR OTHER ENTITY  SELLING  A  NONPRESCRIPTION  PRODUCT
   39  CONTAINING  PSEUDOEPHEDRINE OR EPHEDRINE EXPERIENCES MECHANICAL OR ELEC-
   40  TRONIC FAILURE OF THE ELECTRONIC SALES TRACKING SYSTEM OR  IS  OTHERWISE
   41  UNABLE  TO  COMPLY  WITH  THE ELECTRONIC SALES TRACKING REQUIREMENT, THE
   42  RETAILER SHALL MAINTAIN A  WRITTEN  LOG  OR  AN  ALTERNATIVE  ELECTRONIC
   43  RECORDKEEPING  MECHANISM  UNTIL  SUCH  TIME  AS  THE RETAILER IS ABLE TO
   44  COMPLY WITH THE ELECTRONIC SALES TRACKING REQUIREMENT.
   45    (B) THE REAL-TIME STOP SALE SYSTEM  SHALL  FORWARD  STATE  TRANSACTION
   46  RECORDS IN THE REAL-TIME STOP SALE SYSTEM TO THE APPROPRIATE STATE AGEN-
   47  CY  WEEKLY,  AND  PROVIDE  REAL-TIME  ACCESS  TO THE REAL-TIME STOP SALE
   48  SYSTEM INFORMATION THROUGH THE SYSTEM'S ONLINE PORTAL TO LAW ENFORCEMENT
   49  IN THE STATE AS AUTHORIZED BY THE AGENCY.
   50    (C) THIS SYSTEM SHALL BE CAPABLE OF  GENERATING  A  STOP  SALE  ALERT,
   51  WHICH  SHALL  BE A NOTIFICATION THAT COMPLETION OF THE SALE WOULD RESULT
   52  IN THE SELLER OR PURCHASER VIOLATING THE QUANTITY LIMITS  SET  FORTH  IN
   53  THIS  SECTION.    THE  SELLER  SHALL NOT COMPLETE THE SALE IF THE SYSTEM
   54  GENERATES A STOP SALE ALERT.  THE SYSTEM SHALL CONTAIN AN OVERRIDE FUNC-
   55  TION THAT MAY BE USED BY A DISPENSER OF EPHEDRINE OR PSEUDOEPHEDRINE WHO
   56  HAS A REASONABLE FEAR OF IMMINENT BODILY HARM IF THEY DO NOT COMPLETE  A
       A. 468                              3
    1  SALE.  EACH INSTANCE IN WHICH THE OVERRIDE FUNCTION IS UTILIZED SHALL BE
    2  LOGGED BY THE SYSTEM.
    3    5. A VIOLATION OF ANY PROVISION OF THIS SECTION IS A CLASS A MISDEMEA-
    4  NOR, PUNISHABLE BY FINE ONLY.
    5    (A)  THIS  SECTION  DOES NOT APPLY TO A PERSON WHO OBTAINS THE PRODUCT
    6  PURSUANT TO A VALID PRESCRIPTION.
    7    (B)  NOTHING  IN  THIS  SECTION  REQUIRES  THE  BUYER  TO   OBTAIN   A
    8  PRESCRIPTION FOR THE PURCHASE OF ANY METHAMPHETAMINE PRECURSOR DRUG.
    9    6.  ANY  PERSON,  FIRM, CORPORATION, PARTNERSHIP, ASSOCIATION, LIMITED
   10  LIABILITY COMPANY, OR OTHER ENTITY WHO  KNOWINGLY  VIOLATES  SUBDIVISION
   11  TWO,  THREE,  FOUR  OR  FIVE  OF  THIS SECTION SHALL, FOR THE FIRST SUCH
   12  VIOLATION, BE SUBJECT TO A CIVIL PENALTY OF NOT LESS  THAN  TWO  HUNDRED
   13  FIFTY DOLLARS NOR MORE THAN ONE THOUSAND DOLLARS PER VIOLATION, RECOVER-
   14  ABLE IN AN ACTION BY ANY ENFORCEMENT AUTHORITY DESIGNATED BY ANY MUNICI-
   15  PALITY OR POLITICAL SUBDIVISION.
   16    7.  AN  OWNER, OPERATOR, SUPERVISOR, OR MANAGER OF ANY BUSINESS ENTITY
   17  THAT OFFERS FOR SALE METHAMPHETAMINE PRECURSOR DRUGS WHOSE  EMPLOYEE  OR
   18  AGENT  IS CONVICTED OF OR CHARGED WITH VIOLATING SUBDIVISION TWO, THREE,
   19  FOUR OR FIVE OF THIS SECTION IS NOT SUBJECT TO THE  CIVIL  PENALTIES  OR
   20  CRIMINAL PENALTIES FOR VIOLATING ANY OF SUCH SUBDIVISIONS IF THE PERSON:
   21    (A)  DID  NOT  HAVE  PRIOR KNOWLEDGE OF, PARTICIPATE IN, OR DIRECT THE
   22  EMPLOYEE OR AGENT TO COMMIT THE VIOLATION; AND
   23    (B) DOCUMENTS THAT AN  EMPLOYEE  TRAINING  PROGRAM  WAS  IN  PLACE  TO
   24  PROVIDE  THE EMPLOYEE OR AGENT WITH INFORMATION ON THE STATE AND FEDERAL
   25  LAWS AND REGULATIONS REGARDING METHAMPHETAMINE PRECURSOR DRUGS.
   26    8. THIS SECTION DOES NOT APPLY TO:
   27    (A) METHAMPHETAMINE PRECURSOR DRUGS CERTIFIED BY THE  STATE  BOARD  OF
   28  PHARMACY  AS  BEING MANUFACTURED IN A MANNER THAT PREVENTS THE DRUG FROM
   29  BEING USED TO MANUFACTURE METHAMPHETAMINE; OR
   30    (B) METHAMPHETAMINE PRECURSOR  DRUGS  OBTAINED  PURSUANT  TO  A  VALID
   31  PRESCRIPTION.
   32    9.  THE  STATE BOARD OF PHARMACY, IN CONSULTATION WITH THE DIVISION OF
   33  STATE POLICE, SHALL CERTIFY METHAMPHETAMINE PRECURSOR  DRUGS  THAT  MEET
   34  THE  REQUIREMENTS  OF PARAGRAPH (A) OF SUBDIVISION EIGHT OF THIS SECTION
   35  AND PUBLISH AN ANNUAL LISTING OF SUCH DRUGS.
   36    10. THIS SECTION PREEMPTS ALL LOCAL ORDINANCES OR REGULATIONS  GOVERN-
   37  ING  THE  SALE BY A BUSINESS ESTABLISHMENT OF PRODUCTS CONTAINING EPHED-
   38  RINE OR PSEUDOEPHEDRINE. ALL ORDINANCES ENACTED PRIOR TO  THE  EFFECTIVE
   39  DATE OF THIS SECTION ARE VOID.
   40    S 2. This act shall take effect on the one hundred eightieth day after
   41  it  shall have become a law. Effective immediately, the addition, amend-
   42  ment, and/or repeal of any rule or regulation necessary for  the  imple-
   43  mentation  of this act on its effective date is authorized to be made on
   44  or before such date.